Related Experiment Videos
Ifosfamide in the treatment of soft tissue sarcomas
1Department of Hematology/Medical Oncology, Cleveland Clinic Foundation Cancer Center, OH 44195, USA.
Seminars in Oncology
|June 1, 1996
Abstract:
Ifosfamide is one of the three most active agents in the treatment of soft tissue sarcomas. Ifosfamide-induced urothelial toxicity has been adequately controlled with the use of hydration and the uroprotective agent mesna. This is a review of pilot and phase I and II studies of ifosfamide as a single agent and randomized trials of combination chemotherapy regimens incorporating ifosfamide in the treatment of soft tissue sarcomas. Issues of schedule and dose of ifosfamide will be addressed as well.